Search results
Results from the WOW.Com Content Network
Mayo v. Prometheus, 566 U.S. 66 (2012), was a case decided by the Supreme Court of the United States that unanimously held that claims directed to a method of giving a drug to a patient, measuring metabolites of that drug, and with a known threshold for efficacy in mind, deciding whether to increase or decrease the dosage of the drug, were not patent-eligible subject matter.
The Mayo Clinic noted that it had been paying the taxes while the case was pending in the courts, so the 15-page opinion would not force them to pay back taxes. [28] In March 2010, while the case was pending before the Supreme Court, the Treasury announced that it would not contest refund claims for taxes paid prior to the April 2005 regulation.
The Federal Trade Commission (FTC), along with the New York State Attorney General's office, is angling to give a Wisconsin-based supplement company a legal battle it won't soon forget.Their case ...
Whether a manufacturer may file a petition for review in a circuit (other than the D.C. Circuit) where it neither resides nor has its principal place of business, if the petition is joined by a seller of the manufacturer's products that is located within that circuit. October 4, 2024: January 21, 2025 FDA v. Wages and White Lion Investments, L.L.C.
The Supreme Court has yet to take on an abortion-related case this term. On Monday, it rejected an appeal from the Biden administration to hear a case about a policy meant to ensure patients in ...
Ariosa Diagnostics, Inc. v. Sequenom, Inc., 788 F.3d 1371 (Fed. Cir. 2015), [1] is a controversial decision of the US Federal Circuit in which the court applied the Mayo v. . Prometheus test [2] to invalidate on the basis of subject matter eligibility a patent said to "solve ... a very practical problem accessing fetal DNA without creating a major health risk for the unborn chil
In clinical trials, the non-opioid medication received high patient satisfaction ratings, with 83% reporting "good" to "excellent" pain relief in real-world applications, Cheng noted.
The Supreme Court of the United States granted certiorari in the case in October 2019, agreeing to review the ruling below. [28] [29] With the resignation of Rebekah Gee in January 2020, the case was renamed from June Medical Services, LLC v. Gee [30] upon the appointment of the interim health secretary, Stephen Russo. [30]